- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02719938
Triggered Palliative Care for Advanced Dementia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Alzheimer's disease and related dementias affect 5 million Americans at an annual cost of $215 billion. Dementia is a contributing cause for 1 in 3 deaths, and is the only major cause of death with no effective prevention or treatment. Dementia-specific palliative care is needed to address the unique symptoms and treatment decisions relevant to this disease.
Investigators therefore propose to develop and pilot test a model of palliative care consultation for advanced dementia patients, triggered by hospitalization for a serious acute illness. After systematic refinement of operational protocols and tools with stakeholders, they will enroll persons with advanced dementia plus an acute illness associated with high risk of death in the coming year. Patients will be enrolled with their family decision-makers (N=60 dyads) in a randomized feasibility trial. Intervention dyads will receive specialty palliative care consultation during hospital admission, plus post-discharge collaborative care by their outpatient primary care provider and a palliative care nurse practitioner. Control dyads will receive usual care.
The research objective is to generate preliminary data for a large multi-site randomized controlled trial of a model of palliative care consultation for advanced dementia.
Specific aims are:
Aim 1: To develop a best-practice model of palliative care consultation for advanced dementia triggered by hospital admission for serious acute illness.
Aim 2: To conduct a pilot randomized trial of triggered palliative care consultation for advanced dementia (versus usual care) to demonstrate the feasibility of conducting a larger randomized trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of dementia from Alzheimer's or other underlying cause
- Global Deterioration Scale (GDS) Stage 5, 6 or 7
- acute illness hospitalization
Exclusion Criteria:
- No English-speaking family decision-maker
- Primary physician expects study to be too stressful for family caregiver
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Usual care.
|
|
|
Experimental: Specialty Palliative Care
Specialty inter-disciplinary Palliative Care consultation during hospitalization with post-discharge collaborative care by a Palliative Care Nurse Practitioner and outpatient primary care physician.
Clinical care will be augmented by evidence-based educational materials for dementia caregivers.
|
Specialty inter-disciplinary Palliative Care consultation during hospitalization with post-discharge collaborative care by a Palliative Care Nurse Practitioner and outpatient primary care physician.
Clinical care will be augmented by evidence-based educational materials for dementia caregivers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital / Emergency Visits Per 60 Days (no. of Events/Follow-up Days)
Time Frame: From time of hospital discharge up to 60 days
|
Includes emergency department visits and hospital admissions during measure interval
|
From time of hospital discharge up to 60 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Comfort End of Life in Dementia (CAD-EOLD)
Time Frame: 60 days
|
Comfort at the End of Life in Dementia (CAD-EOLD) instrument, consisting of 14 Likert-scaled items measuring comfort in the final phase of life with dementia.
Scores range from 14-42, with higher scores indicting greater comfort.
|
60 days
|
|
Caregiver Strain
Time Frame: Interview at 60 days after hospitalization
|
Family Distress in Advanced Dementia instrument, a 21 item questionnaire designed to detect strain in family caregivers in dementia.
Caregivers are asked a series of items about emotional distress, preparedness, and relations with healthcare providers scored 1-5, with higher scores indicting greater distress.
|
Interview at 60 days after hospitalization
|
|
Percent of Participants With Referral to Hospice or Outpatient Palliative Care From Discharge to 60 Days Follow-Up
Time Frame: From time of hospital discharge up to 60 days
|
Percent of patients with referral to hospice or outpatient palliative care from discharge to 60 days follow-up from family interviews.
|
From time of hospital discharge up to 60 days
|
|
Percent of Participants With Physician Orders for Life Sustaining Treatment (POLST)
Time Frame: From time of hospital discharge up to 60 days
|
Percent of participants with POLST (Physician Orders for Life Sustaining Treatment) form completed and signed
|
From time of hospital discharge up to 60 days
|
|
Number of Palliative Care Domains in Treatment Plan
Time Frame: From time of hospital discharge up to 60 days
|
Number of palliative care domains addressed in treatment plan, using the Palliative Care Domain score which is scored 0 (not addressed) or 1 (addressed) for each of 10 possible domains of a palliative care treatment plan -- prognosis, overall goals of care, physical symptoms, psychiatric symptoms, spiritual needs, and 5 treatment preferences: resuscitation, artificial feeding, intravenous fluids, antibiotics, and hospitalization.
Scores are summed for a total possible score of 0-10, with higher scores indicating greater attention to palliative care needs in the treatment plan.
|
From time of hospital discharge up to 60 days
|
|
Number of Participants With Burdensome Treatments
Time Frame: From time of hospital discharge up to 60 days
|
Number of participants with burdensome treatments, defined as a count of participants with any use of the following treatments: feeding tube, central intravenous line, surgical procedure, intensive care transfer, ventilator use, cardiopulmonary resuscitation use at any time during the time frame of measurement.
|
From time of hospital discharge up to 60 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laura Hanson, MD, MPH, University of North Carolina, Chapel Hill
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-1350
- R21AG052140 (U.S. NIH Grant/Contract)
- Pilot & Exploratory Project (Other Identifier: National Palliative Care Research Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on Specialty Palliative Care
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeCompletedLung Cancer | Advanced Cancer | Gastrointestinal CancerUnited States
-
NYU Langone HealthPatient-Centered Outcomes Research Institute; University of California, San... and other collaboratorsCompletedAdvanced Cancer | End Stage Organ FailureUnited States
-
University of PittsburghMassachusetts General Hospital; National Institute on Aging (NIA)CompletedCritical IllnessUnited States
-
Allina Health SystemCompleted
-
Augusto CaraceniRecruitingCancer | Frailty | Palliative Care | Outpatient | Palliative Care, Health Services | Patient Reported Outcome Measurements | Patient Reported Outcome (PRO)Italy
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Palliative Care Research Cooperative...CompletedLung CancerUnited States
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong KongCompletedPalliative Care | Renal Failure, End-stageHong Kong
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedHeart Diseases | Cardiovascular Diseases | Heart FailureUnited States
-
Massachusetts General HospitalAmerican Society of Clinical OncologyCompletedNon-small Cell Lung CancerUnited States